Skip to main content
. 2022 Jun 28;22:522. doi: 10.1186/s12884-022-04828-3

Table 1.

Baseline characteristics

Item Control (n = 61) Nonsurgery (n = 59) Surgery (n = 42) P value
Age, y 32.85 ± 4.20 34.73 ± 4.69 33.41 ± 4.24 0.062
  < 37 years 43(75.4) 44 (76.6) 32 (76.2) 0.983
  ≥ 37 years 14 (24.6) 15 (25.4) 10 (23.8)
Infertility duration, y 5.05 ± 3.23 5.19 ± 4.02 4.21 ± 2.55 0.325
BMI, kg/m2 23.05 ± 3.05 23.09 ± 3.17 22.43 ± 3.07 0.538
Basal FSH, mIU/L 6.13 ± 1.55 7.46 ± 2.29a 7.37 ± 2.33b 0.001
Basal LH, mIU/L 4.51 ± 6.21 4.00 ± 2.46 4.21 ± 1.74 0.499
Basal E2, ng/L 47.82 ± 21.17 48.94 ± 22.00 47.62 ± 18.32 0.941
Basal testosterone, ng/L 40.10 ± 16.22 36.23 ± 16.89 35.34 ± 17.39 0.309

Values are presented as the mean standard deviation or n (%)

BMI Body Mass Index, FSH Follicle Stimulating Hormone, LH Luteinizing Hormone, E2 oestradiol

a shows that there were significant differences between the nonsurgery group and the control group

b shows that there were significant differences between the surgery group and the control group